In previous epidemiological studies, we have shown that increased levels of galectin-4 (Gal-4) are linked with prevalent and incident diabetes [1], as well as increased risk of future myocardial infarction, heart failure, cardiovascular, and all-cause mortality [2]. The gene discussed is LGALS4; the disease is heart failure.